Oral Squamous Cell Carcinoma - Symptoms, Causes, Treatment & Prevention

Overview

Oral squamous cell carcinoma (OSCC) is a malignant tumor that arises from the flat, scale‑like cells (squamous cells) lining the oral cavity and oropharynx. It accounts for more than 90 % of all oral cancers.

Who it affects: OSCC can develop at any age, but the risk rises sharply after age 40. Historically, the disease has been more common in men than women (approximately 2–3 : 1). However, rates among women are rising in many countries, largely because of changes in tobacco and alcohol use patterns.

Prevalence: According to the World Health Organization (WHO), there were an estimated 300,000 new cases of oral cavity cancer worldwide in 2020, and > 90 % were squamous cell carcinomas. In the United States, the American Cancer Society reports about 53,000 new cases of oral & oropharyngeal cancer each year, with a 5‑year survival of roughly 66 % when detected early.¹

Symptoms

OSCC may develop slowly, and early lesions often cause few or no symptoms. When symptoms appear, they can involve any part of the mouth, lips, tongue, floor of mouth, gums, or throat. Common signs include:

• Persistent ulcer or sore that does not heal within 2–3 weeks.
• Red or white patches (erythroplakia or leukoplakia) that may be flat or slightly raised.
• Unexplained lump or thickening of the tongue, cheek, jaw, or neck.
• Difficulty chewing, swallowing, or moving the tongue.
• Persistent pain or burning sensation in the mouth or lips.
• Voice changes (hoarseness, nasality) when the tumor involves the oropharynx.
• Ear pain (referred pain) without an ear infection.
• Numbness or loss of sensation in the mouth, lips, or chin (described as “numb chin syndrome”).
• Unexplained weight loss or fatigue.
• Bleeding from a lesion after minor trauma.
• Loose teeth or ill‑fitting dentures due to bone invasion.

Because many of these signs overlap with benign conditions (canker sores, oral infections, etc.), any lesion persisting more than two weeks warrants a dental or medical evaluation.

Causes and Risk Factors

OSCC is multifactorial. No single cause is required, but several well‑established risk factors dramatically increase the likelihood of developing the disease.

Tobacco Use

• Smoked tobacco (cigarettes, cigars, pipe) – risk is 4–7 × higher.
• Smokeless tobacco (chewing tobacco, snuff) – especially prevalent in South Asia; risk up to 10 × higher.

Alcohol Consumption

• Heavy, regular drinking (≥ 2 drinks/day for women, ≥ 3 for men) synergizes with tobacco, raising risk 15‑fold.

Human Papillomavirus (HPV)

• HPV‑16 infection is a major cause of oropharyngeal OSCC, particularly in younger, non‑smoking patients.
• HPV‑positive tumors tend to have a better prognosis.

Other Factors

• Chronic irritation from ill‑fitting dentures, sharp teeth, or persistent oral lesions.
• Sun exposure to the lips (lip cancer) – UV‑B radiation is a proven carcinogen.
• Dietary deficiencies – low intake of fruits, vegetables, and antioxidants.
• Immunosuppression – HIV infection, organ transplant recipients, or long‑term corticosteroid therapy.
• Genetic predisposition – familial cancer syndromes (e.g., Fanconi anemia) increase risk.
• Age and sex – risk climbs after age 40; male sex is an independent factor.

Diagnosis

Early and accurate diagnosis is essential for curative treatment. The diagnostic pathway typically involves the following steps:

Clinical Examination

• Comprehensive oral and head‑and‑neck exam by a dentist, oral surgeon, or ENT specialist.
• Palpation of lymph nodes in the neck to detect metastatic spread.

Imaging Studies

• Contrast‑enhanced CT scan – assesses bone invasion and tumor extent.
• MRI – provides superior soft‑tissue detail, especially for tongue and floor‑of‑mouth lesions.
• PET‑CT – useful for staging, detecting distant metastases, and monitoring treatment response.

Biopsy & Pathology

• Incisional biopsy (most common) – a small tissue sample is taken under local anesthesia.
• Excisional biopsy – removal of the entire lesion if it is small and appears resectable.
• Pathology confirms squamous cell carcinoma, grades differentiation (well, moderate, poor), and may assess margins.
• Testing for HPV DNA/RNA (p16 immunohistochemistry) guides prognosis and therapy.

Staging

The AJCC (American Joint Committee on Cancer) 8th edition TNM system stages OSCC from I (early) to IV (advanced) based on tumor size (T), nodal involvement (N), and distant metastasis (M). Accurate staging determines treatment planning.

Treatment Options

Treatment is individualized, taking into account tumor stage, location, HPV status, patient health, and personal preferences. Multidisciplinary teams (surgeon, radiation oncologist, medical oncologist, speech therapist, dietitian) collaborate to achieve the best outcome.

Surgery

• Wide local excision with clear margins (≥ 1 cm) is the cornerstone for early‑stage disease.
• Neck dissection (selective, modified radical, or radical) removes potentially involved lymph nodes.
• Reconstructive techniques (free flap, grafts) restore function and appearance after extensive resections.

Radiation Therapy

• Definitive radiotherapy (66‑70 Gy) for patients who cannot undergo surgery or for adjuvant treatment after surgery.
• Intensity‑Modulated Radiation Therapy (IMRT) spares salivary glands and reduces xerostomia.

Chemoradiation

• Concurrent weekly cisplatin (40 mg/m²) with radiation is standard for advanced (stage III–IV) disease.
• Alternative agents (cetuximab, carboplatin/5‑FU) may be used in cisplatin‑ineligible patients.

Targeted & Immunotherapy (for recurrent/metastatic disease)

• EGFR inhibitor cetuximab combined with radiation or chemotherapy.
• PD‑1 inhibitors (nivolumab, pembrolizumab) have shown survival benefit in platinum‑refractory metastatic OSCC.²

Supportive & Lifestyle Measures

• Smoking cessation programs, alcohol counseling, and nutritional support.
• Dental hygiene optimization before radiation to prevent osteoradionecrosis.
• Physical therapy and speech‑language pathology to preserve swallowing and speech.

Living with Oral Squamous Cell Carcinoma

Even after successful treatment, many patients need ongoing care to maintain quality of life.

Oral hygiene

• Brush twice daily with a soft brush; use alcohol‑free fluoride toothpaste.
• Floss gently; consider a water flosser if dexterity is limited.
• Regular dental check‑ups every 3–6 months, especially after radiation.

Nutrition

• High‑protein, high‑calorie diet to counteract weight loss.
• Small, frequent meals; smoothies or pureed foods if chewing is painful.
• Consult a dietitian for supplements (e.g., oral nutrition shakes).

Speech & Swallowing

• Engage a speech‑language pathologist early for exercises that improve tongue mobility.
• Practice safe swallowing techniques to reduce aspiration risk.

Emotional health

• Join support groups (e.g., American Cancer Society, Mouth Cancer Foundation).
• Consider counseling or psychotherapy to address anxiety, depression, or body‑image concerns.

Follow‑up schedule

• First year: exam & imaging every 1–3 months.
• Years 2‑5: every 4–6 months.
• After 5 years: annual review if disease‑free.
• Any new lesion, pain, or unexplained symptoms should prompt an immediate visit.

Prevention

Because many risk factors are modifiable, prevention strategies can dramatically lower OSCC incidence.

• Tobacco cessation – seek counseling, nicotine replacement, or medications (varenicline, bupropion).
• Limit alcohol – no more than 1 drink per day for women, 2 for men.
• HPV vaccination – the 9‑valent vaccine protects against HPV‑16/18; recommended for ages 9‑45.
• Sun protection for lips – use lip balm with SPF 30+.
• Balanced diet – at least 5 servings of fruits/vegetables daily provide antioxidants.
• Regular dental exams – early detection of leukoplakia or erythroplakia.
• Oral hygiene – brushing, flossing, and limiting sugary foods to reduce chronic inflammation.

Complications

If left untreated or if treatment is delayed, OSCC can lead to serious, sometimes life‑threatening complications:

• Local invasion of the jawbone, tongue, or floor of mouth causing severe pain, loss of function, and pathological fractures.
• Regional metastasis to cervical lymph nodes, which reduces survival rates markedly.
• Distant metastasis to lungs, liver, or bone in advanced disease.
• Airway obstruction from a large oropharyngeal mass – can cause acute respiratory distress.
• Osteoradionecrosis after radiation, especially if teeth are extracted post‑therapy.
• Chronic xerostomia (dry mouth) leading to dental decay and difficulty swallowing.
• Functional deficits – speech, taste, and nutritional problems.
• Psychosocial impact – depression, anxiety, and social isolation.

When to Seek Emergency Care

---

References:

1. Mayo Clinic. Oral Cancer – Symptoms and Causes. https://www.mayoclinic.org. Accessed May 2026.
2. Ferris RL et al. Nivolumab for Recurrent Head and Neck Cancer. New England Journal of Medicine. 2016;374:2115‑2126. DOI:10.1056/NEJMoa1509714.
3. American Cancer Society. Cancer Facts & Figures 2025. https://www.cancer.org.
4. World Health Organization. Global Cancer Observatory: Oral cavity cancer. https://gco.iarc.fr.
5. National Cancer Institute. Head and Neck Cancers—PDQ®–Patient Version. https://www.cancer.gov.